Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 18 results.
User Information
Export Records
  1. 1.   Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis
  2. Xie, Yingda L.; de Jager, Veronique R.; Chen, Ray Y.; Dodd, Lori E.; Paripati, Praveen; Via, Laura E.; Follmann, Dean; Wang,Jing; Lumbard, Keith; Lahouar, Saher; Malherbe, Stephanus T.; Andrews, Jenna; Yu, Xiang; Goldfeder, Lisa C.; Cai, Ying; Arora, Kriti; Loxton, Andre G.; Vanker, Naadira; Duvenhage,Michael; Winter, Jill; Song, Taeksun; Walzl, Gerhard; Diacon, Andreas H.; Barry, Clifton E.
  3. Science Translational Medicine. 2021, Feb 3; 13(579):
  1. 2.   Generation and validation of novel conditional flox and inducible Cre alleles targeting fibroblast growth factor 18 (Fgf18)
  2. Hagan, Andrew S; Boylan,Michael; Smith, Craig; Perez-Santamarina, Estela; Kowalska, Karolina; Hung, Irene H; Lewis, Renate M; Hajihosseini, Mohammad K; Lewandoski,Mark; Ornitz, David M
  3. Developmental dynamics : an official publication of the American Association of Anatomists. 2019, JUL 22;
  1. 3.   Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness
  2. Boufraqech, Myriem; Patel, Dhaval; Nilubol, Naris; Powers, Astin; King, Timothy; Shell, Jasmine; Lack,Justin; Zhang, Lisa; Gara, Sudheer Kumar; Gunda, Viswanath; Klubo-Gwiezdzinska, Joanna; Kumar, Suresh; Fagin, James; Knauf, Jeffrey; Parangi, Sareh; Venzon, David; Quezado, Martha; Kebebew, Electron
  3. THYROID. 2019, Jan 1; 29(1): 79-92.
  1. 4.   Poloxamer P85 increases anticancer activity of Schiff base against prostate cancer in vitro and in vivo
  2. Demirci, Selami; Dogan, Aysegul; Turkmen, Nese Basak; Telci, Dilek; Caglayan, Ahmet B.; Beker, Mustafa C.; Kilic, Ertugrul; Ozkan, Ferda; Dede, Bulent; Sahin, Fikrettin
  3. ANTI-CANCER DRUGS. 2017, Sep; 28(8): 869-879.
  1. 5.   Schiff base-Poloxamer P85 combination demonstrates chemotherapeutic effect on prostate cancer cells in vitro.
  2. Demirci, Selami; Dogan, Aysegül; Türkmen, Nese Basak; Telci, Dilek; Rizvanov, Albert A; Sahin, Fikrettin
  3. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2017, Feb; 86: 492-501.
  1. 6.   Cre-mediated recombination can induce apoptosis in vivo by activating the p53 DNA damage-induced pathway
  2. Zhu, J. J.; Nguyen, M. T.; Nakamura, E.; Yang, J. M.; Mackem, S.
  3. Genesis. 2012, Feb; 50(2): 102-111.
  1. 7.   Reconciling Apparent Conflicts between Mitochondrial and Nuclear Phylogenies in African Elephants
  2. Ishida, Y.; Oleksyk, T. K.; Georgiadis, N. J.; David, V. A.; Zhao, K.; Stephens, R. M.; Kolokotronis, S. O.; Roca, A. L.
  3. Plos One. 2011, Jun; 6(6): 16.
  1. 8.   A versatile valve-enabled microfluidic cell co-culture platform and demonstration of its applications to neurobiology and cancer biology
  2. Gao, Y. D.; Majumdar, D.; Jovanovic, B.; Shaifer, C.; Lin, P. C.; Zijlstra, A.; Webb, D. J.; Li, D. Y.
  3. Biomedical Microdevices. 2011, Jun; 13(3): 539-548.
  1. 9.   Structure-activity relationships of ustiloxin analogues
  2. Joullie, M. M.; Berritt, S.; Hamel, E.
  3. Tetrahedron Letters. 2011, Apr; 52(17): 2136-2139.
  1. 10.   Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution
  2. Dobrovolskaia, M. A.; Aggarwal, P.; Hall, J. B.; McNeil, S. E.
  3. Molecular Pharmaceutics. 2008 5(4): 487-495.
  1. 11.   Generation of a conditional Ppap2b/Lpp3 null allele
  2. Escalante-Alcalde, D.; Sanchez-Sanchez, R.; Stewart, C. L.
  3. Genesis. 2007, Jul; 45(7): 465-469.
  1. 12.   Vascular defects and liver damage by the acute inactivation of the VHL gene during mouse embryogenesis
  2. Hong, S. B.; Furihata, M.; Baba, M.; Zbar, B.; Schmidt, L. S.
  3. Laboratory Investigation. 2006, Jul; 86(7): 664-675.
  1. 13.   Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration
  2. Akassoglou, K.; Malester, B.; Xu, J. X.; Tessarollo, L.; Rosenbluth, J.; Chao, M. V.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(14): 5075-5080.
  1. 14.   Facile photochemical synthesis of mixed siloxyacetal glycosides as potential pH-sensitized prodrugs for selective treatment of solid tumors
  2. Svarovsky, S. A.; Taraban, M. B.; Barchi, J. J.
  3. Organic & Biomolecular Chemistry. 2004 2(21): 3155-3161.
  1. 15.   Patterns of molecular genetic variation among African elephant populations
  2. Comstock, K. E.; Georgiadis, N.; Pecon-Slattery, J.; Roca, A. L.; Ostrander, E. A.; O'Brien, S. J.; Wasser, S. K.
  3. Molecular Ecology. 2002 11(12): 2489-2498.
  1. 16.   Brain-derived neurotrophic factor is essential for opiate- induced plasticity of noradrenergic neurons
  2. Akbarian, S.; Rios, M.; Liu, R. J.; Gold, S. J.; Fong, H. F.; Zeiler, S.; Coppola, V.; Tessarollo, L.; Jones, K. R.; Nestler, E. J.; Aghajanian, G. K.; Jaenisch, R.
  3. Journal of Neuroscience. 2002 22(10): 4153-4162.
  1. 17.   Testing of new agents in childhood cancer preclinical models: Meeting summary
  2. Houghton, P. J.; Adamson, P. C.; Blaney, S.; Fine, H. A.; Gorlick, R.; Haber, M.; Helman, L.; Hirschfeld, D.; Hollingshead, M. G.; Israel, M. A.; Lock, R. B.; Maris, J. M.; Merlino, G.; Patterson, W.; Reynolds, C. P.; Shannon, K.; Yu, A.; Yu, J.; Smith, M. A.
  3. Clinical Cancer Research. 2002 8(12): 3646-3657.
  1. 18.   Gastrin Receptor Expression and Function During Rapid Transformation of the Enterochromaffin-Like Cells in an African Rodent
  2. Tang, L. H.; Luque, E. A.; Efstathiou, J. A.; Bortecen, K. H.; Kidd, M.; Tarasova, N. I.; Modlin, I. M.
  3. Regulatory Peptides. 1997 72(1): 9-18.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel